The Psychedelics Analyst (@thepsychedelica) 's Twitter Profile
The Psychedelics Analyst

@thepsychedelica

An unfiltered view of the Psychedelics industry from a recovering professional equity analyst.

DM's are welcome

ID: 1244140621767507969

calendar_today29-03-2020 05:53:47

292 Tweet

5,5K Takipçi

651 Takip Edilen

The Psychedelics Analyst (@thepsychedelica) 's Twitter Profile Photo

Congrats to MindMed it looks like they are very close to their NASDAQ listing! If you like it, you should be buying it on this weakness and ahead of their NASDAQ listing $MMED

The Psychedelics Analyst (@thepsychedelica) 's Twitter Profile Photo

Society is taking notice. Today maybe 5% realize what these medicines can do. This number is growing rapidly. Don't lose sight of this key trend.

Society is taking notice. 

Today maybe 5% realize what these medicines can do. This number is growing rapidly. 

Don't lose sight of this key trend.
PsychedelicStockWatch (@psychstockwatch) 's Twitter Profile Photo

Toronto Star article on the resurgence of #LSD and "bicycle day". $FTRP gets mentioned in the article. #psychedelics #psychedelicstocks $FTRPF $PSYK thestar.com/life/health_we…

The Psychedelics Analyst (@thepsychedelica) 's Twitter Profile Photo

A big day for $MMED who announced their NASDAQ listing earlier today. The stock is up 40% The next company to uplist to NASDAQ will be $DRUG if you want to play that trade

Grateful Daytrader ⚡️ (@gr8fuldaytrader) 's Twitter Profile Photo

I mixed up the prices on this btw, $6 was the CAD price on $DRUG - nevertheless my thoughts still stand around their uplist and $BMBIF is a great value at $4.60 imo Worth a bag to sit on and wait for blast off...

WallStreetMiner (@wallstreetminer) 's Twitter Profile Photo

We all remember how the MJ market had its long dry periods of nothing, trading sideways, but then continued to return bigger and more feirce every time. So far the Psychedelic market has been very similar. It's far from over.

Microdose Psychedelic Insights (@microdosehq) 's Twitter Profile Photo

$FTRP Field Trip Executive chair and co-founder Ronan Levy and former Senate Majority Leader @TomDaschle join ‘Squawk on the Street’ on CNBC to make the case for investing in #psychedelic therapies, the drugs involved and more. cnb.cx/3zt2ixI

The Psychedelics Analyst (@thepsychedelica) 's Twitter Profile Photo

Today Cybin $CYBN got their conditional approval to list from the NYSE. Should be about 3 weeks until they are trading. BUY THE STOCK